China Health Group (673.HK) Stock Price

China Health Group Price

CLOSED
0.28
​
Market closed

Revenue has compounded at 9.6% per year over the past 19 years to 38.94 M HKD. China Health Group's net margin stands at -174.1%, down from -8.8% several years earlier.

China Health Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

China Health Group business model & stock analysis

China Health Group Ltd generates revenue through four core business segments. The Trading of Medical Equipment And Consumables segment sells medical equipment and consumables to hospitals and healthcare facilities. The Hospital Management Service segment operates Shuangluan Hospital, Anping Bo’ai Hospital, Red Cross Hospital of Luanping County, and Hong Fu Eldercare and Nursing Home of Luanping County, providing healthcare services. The Property Investment segment acquires properties related to Anping Bo’ai Hospital and earns rental income from these assets. The Business Factoring segment offers factoring services specifically to hospitals, facilitating their financial operations. The company's primary customers are hospitals, healthcare facilities, and elderly care institutions. Medical equipment and consumables are sold to these institutions, while factoring services target hospital financial departments. Rental income comes from properties leased to hospital-related entities. The segments collectively serve the healthcare industry with a focus on medical supply distribution, hospital operations, property management, and financial services for healthcare providers. China Health Group Ltd's revenue streams are derived from direct sales of medical products, management fees from hospital operations, rental income from properties, and factoring fees from financial services. The company's business model integrates physical healthcare services with financial solutions, targeting hospitals and elderly care facilities as key clients. Its operations are structured around four distinct segments that collectively support the healthcare sector's supply chain and financial needs.

Frequently asked questions about China Health Group

Converted at the current exchange rate, the China Health Group share trades at 0.03 EUR (0.28 HKD).

The revenue cannot currently be calculated for China Health Group.

The profit cannot currently be calculated for China Health Group.

The P/E ratio cannot be calculated for China Health Group at the moment.

The P/S cannot be calculated for China Health Group currently.

The Eulerpool Quality Score for China Health Group is 3/10.

The ISIN of China Health Group is BMG2107P2040. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of China Health Group is 673.HK. The ticker symbol is used to trade China Health Group shares on the stock exchange.

Fair ValueTerminal
0.23 HKD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
284,255.47 HKD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
HKD
Initial public offering
Oct 14, 1996
ISIN
BMG2107P2040
Cusip
G2107P204
Market capitalization
374.96 M HKDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
7.21
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
5,838.93 %
Last updated Nov 6, 2026, 3:38 AM

China Health Group Peer Group

China Health Group FIGI

673:HK · BBG000BLT259